Commissioner Califf Touts Use Of EHRs To Help End Clinical Trial Disparities
This article was originally published in The Gray Sheet
Newly minted FDA Commissioner Robert Califf admitted that electronic health records used to do “a lousy job” of allowing device and drug trial managers to aggregate data from various subgroups, but EHRs have improved and should be tapped for design of pragmatic clinical trials to tease out demographic subgroup data.
You may also be interested in...
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.